— Know what they know.
Not Investment Advice

ALID OTC

Allied Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -95.5% 3Y: -99.8% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $57748 mcap · 84M float · 0.0003% daily turnover · Short 32% of daily vol

Balance Sheet Trends

Total Assets
$2M -64.4% ▼
5Y CAGR: +386.7%
Total Liabilities
$9M +26.5% ▲
5Y CAGR: +199.0%
Shareholders Equity
-$7M -436.8% ▼
Cash & Investments
$210K +118.4% ▲
5Y CAGR: +208.1%
Total Debt
$6M +15.4% ▲
Net Debt
$6M +13.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$103$94K$420K$96K$210K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$103$94K$420K$96K$210K
Net Receivables$0$0$83K$121K$134K
Inventory$0$53K$136K$999K$108K
Other Current Assets$0$52K$278K$25K$19K
Total Current Assets$103$198K$916K$1M$471K
Property, Plant & Equip.$0$598K$4M$4M$2M
Goodwill & Intangibles$0$3M$196K$195K$40K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$3M$0$0$0
Total Non-Current Assets$0$7M$4M$5M$2M
Total Assets$103$7M$5M$6M$2M
— Liabilities —
Accounts Payable$15K$1M$0$2M$2M
Short-Term Debt$0$2M$4M$5M$6M
Deferred Revenue$0-$1M$0$0-$2M
Other Current Liabilities$45K$0$2M-$1M-$2M
Total Current Liabilities$60K$3M$5M$7M$9M
Long-Term Debt$0$333K$222K$165K$99K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$15K$333K$222K$165K$99K
Total Liabilities$60K$3M$6M$7M$9M
— Equity —
Common Stock$13K$9K$8K$9K$10K
Retained Earnings-$85K-$8M-$19M-$35M-$46M
Accumulated OCI$0-$642K-$615K-$898K-$771K
Total Stockholders Equity-$60K$4M-$971K-$1M-$7M
Total Liabilities & Equity$103$7M$5M$6M$2M
— Key Metrics —
Total Debt$0$2M$4M$5M$6M
Net Debt-$103$2M$3M$5M$6M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms